Adapsyn Bioscience and McMaster University were selected for funding in Round 9 of Genome Canada's Genomic Applications Partnership Program (GAPP). The funds awarded will be used to apply the Adapsyn genomics platform to the identification, isolation and characterization of immune modulators from the human microbiome.